From Medscape Oncology

Coverage from the

European Hematology Association (EHA) 2022 Annual Meeting

June 09 - 12, 2022; Vienna, Austria and Virtual/Online

June 09 - 12, 2022 Vienna, Austria and Virtual/Online

Conference News

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from EHA 2021

  • 'Impressive Results' With CAR T-cell in R/R Follicular Lymphoma 'Impressive Results' With CAR T-cell in R/R Follicular Lymphoma Updated results show that patients who received the novel CAR T-cell therapy had significantly improved overall survival than comparable patients who received other current therapies.
  • Zanubrutinib Better Than Ibrutinib in CLL/SLL? Zanubrutinib Better Than Ibrutinib in CLL/SLL? An interim phase 3 clinical trial analysis shows encouraging progression-free survival and lower cardiac toxicity in patients with relapsed/refractory chronic lymphocytic leukemia (CLL).
  • Multiple Myeloma Highlights From EHA 2021 Multiple Myeloma Highlights From EHA 2021 Prof Pieter Sonneveld discusses the latest advances in multiple myeloma from EHA 2021, including novel immune approaches, management of newly diagnosed disease, and options for high-risk patients.

Previous Coverage